Skip to search formSkip to main contentSkip to account menu

mastoparan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An in vivo assay for phospholipase D (PLD; EC 3.1.4.4) activity, based on its transphosphatidylation property, is described in… 
2013
2013
Larval Manduca prothoracic gland cells in vitro responded to prothoracicotropic hormone (PTTH) from neurosecretory cells of the… 
Review
2010
Review
2010
スズメバチ毒素のマストパランはヒスタミン遊離活性を指標に見出された14個のアミノ酸残基からなるペプチドである.マストパランは三量体Gタンパク質の活性化作用を有し,活性化されたG… 
2008
2008
The present invention is cancer, autoimmune disease, fibrotic disease, inflammatory disease, neurodegenerative disease… 
2008
2008
The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt as a therapeutic… 
2001
2001
Muscarinic acetylcholine receptors (mAChR, m2 subtype) are phosphorylated in an agonist-dependent manner by a G protein-coupled… 
1999
1999
AIM To study whether polysaccharide sulphate (PSS) can block cortical neuronal apoptosis induced by mastoparan. METHODS Three… 
1998
1998
AIM To study the mechanisms of neuronal death induced by mastoparan(MP), a wasp venom peptide. METHODS Using Fura 2/AM probe with… 
1995
1995
The levels of two small stress proteins, hsp27 and alpha B crystallin, were low in C6 glioma cells confluency. However, the…